文献速递皮肤肿瘤

激活cGMP依赖性蛋白激酶通过干扰EGF/EGFR通路抑制黑色素瘤生长与侵袭

Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway.
PubMed 文献 · J Invest Dermatol · 2021-07-13

本研究评估两种聚乙二醇连接的二聚体cGMP类似物(PA4和PA5)对黑色素瘤的抗癌作用。PA5在黑色素瘤细胞系、患者来源的转移性黑色素瘤三维球体及斑马鱼黑色素瘤模型中均显示最有效,可显著降低细胞活力、球体大小和侵袭,且对健康黑素细胞无毒性。PA5通过激活蛋白激酶G干扰EGF通路,降低EGFR磷酸化及下游AKT和ERK1/2的活化形式,并显著减少斑马鱼中的转移过程。

要点

  • PA5是cGMP类似物中最有效的抗黑色素瘤化合物。
  • PA5对黑色素瘤细胞和患者来源球体有显著抑制作用,对健康黑素细胞无毒性。
  • PA5通过激活PKG干扰EGF/EGFR通路并减少斑马鱼转移。

核心结论

  • cGMP类似物PA5通过激活蛋白激酶G干扰EGF/EGFR通路,抑制黑色素瘤生长和侵袭,为黑色素瘤治疗提供潜在策略。

研究设计与样本

  • 研究评估了两种聚乙二醇连接的二聚体cGMP类似物PA4和PA5,在黑色素瘤细胞系、患者来源的转移性黑色素瘤三维球体、健康黑素细胞及斑马鱼黑色素瘤模型中进行实验。

主要发现

  • PA5被鉴定为对黑色素瘤细胞系及患者来源的转移性黑色素瘤三维球体最有效的化合物。
  • PA5显著降低黑色素瘤球体的细胞活力、大小和侵袭。
  • PA5对健康黑素细胞未观察到毒性效应,显示肿瘤特异性。
  • PA5降低黑色素瘤细胞中EGFR磷酸化及磷酸化的蛋白激酶B和细胞外信号调节激酶1/2水平。
  • PA5显著减少斑马鱼模型中的转移过程。

关键数值与推荐

  • PA5能结合并激活蛋白激酶G,通过降低EGFR磷酸化及下游磷酸化AKT和ERK1/2干扰EGF通路。

临床怎么用

  • PA5作为cGMP类似物,未来可能成为黑色素瘤的潜在治疗策略,尤其针对转移性黑色素瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Drug resistance mechanisms still characterize metastatic melanoma, despite the new treatments that have been recently developed. Targeting of the cGMP/protein kinase G pathway is emerging as a therapeutic approach in cancer research. In this study, we evaluated the anticancer effects of two polymeric-linked dimeric cGMP analogs able to bind and activate protein kinase G, called protein kinase G activators (PAs) 4 and 5. PA5 was identified as the most effective compound on melanoma cell lines as well as on patient-derived metastatic melanoma cells cultured as three-dimensional spheroids and in a zebrafish melanoma model. PA5 was able to significantly reduce cell viability, size, and invasion of melanoma spheroids. Importantly, PA5 showed a tumor-specific outcome because no toxic effect was observed in healthy melanocytes exposed to the cGMP analog. We defined that by triggering protein kinase G, PA5 interfered with the EGF pathway as shown by lower EGFR phosphorylation and reduction of activated, phosphorylated forms of protein kinase B and extracellular signal‒regulated kinase 1/2 in melanoma cells. Finally, PA5 significantly reduced the metastatic process in zebrafish. These studies open future perspectives for the cGMP analog PA5 as a potential therapeutic strategy for melanoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Quadri M, Comitato A, Palazzo E, et al. Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway. J Invest Dermatol. 2021. PMID: 34265328. doi:10.1016/j.jid.2021.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。